Search

PLANTATION, Florida and HOUSTON, Texas, Oct. 7, 2024 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=4270518-1&h=2537838533&u=https%3A%2F%2Fwww.gbibio.com%2F&a=GBI+Biomanufacturing, a leading Contract Development and Manufacturing Organization (CDMO), and https://c212.net/c/link/?t=0&l=en&o=4270518-1&h=3458545142&u=https%3A%2F%2Fallterum.com%2F&a=Allterum+Therapeutics, a https://c212.net/c/link/?t=0&l=en&o=4270518-1&h=2818386439&u=https%3A%2F%2Fwww.fannininnovation.com%2F&a=Fannin-Founded+Company, are pleased to announce a manufacturing partnership [...]

$2.9 Million Received From Wellcome for DNA-Based Delivery of Antiviral Antibodies for Zika and Influenza Prevention, Focusing on Preclinical Development of a Potent Anti-Zika Antibody and Optimizing Antibody Cocktail Delivery [...]

GlycoNex to advance development of novel pro-antibody cancer drugs that enhance tumor suppression while minimizing off-site binding to healthy tissues to improve safety and tolerability NEW TAIPEI CITY, Taiwan, May [...]

HOLON, Israel, May 16, 2024 /PRNewswire/ -- http://www.cgen.com/(Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced the online publication of a [...]

CAMBRIDGE, England, May 14, 2024 /PRNewswire/ -- Alchemab Therapeutics (Alchemab), an antibody discovery company identifying naturally occurring antibodies from individuals resilient to disease, today announces the publication of a peer [...]

BAR HARBOR, Maine and MOUNTAIN VIEW, Calif., May 10, 2024 /PRNewswire/ -- The Jackson Laboratory (JAX), an independent, nonprofit biomedical research organization, and AbTherx, an innovator in biotechnology, announced a [...]

HOLON, Israel, April 10, 2024 /PRNewswire/ -- http://www.cgen.com/(NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced the simultaneous online publication of [...]

DUBLIN, March 28, 2024 /PRNewswire/ -- The https://www.researchandmarkets.com/report/antibody-drug?utm_source=CI&utm_medium=PressRelease&utm_code=rthgft&utm_campaign=1949004+-+Global+Antibody+Therapeutic+Industry+Research+2023-2024+%26+2033%3a+Exploring+the+Expanding+Role+in+Managing+Cancer%2c+Autoimmune+Disorders%2c+and+Infectious+Diseases&utm_exec=chdomspi report has been added toResearchAndMarkets.com's offering. The global antibody therapeutic market is projected to experience remarkable growth to 2033 The escalating prevalence [...]

HONG KONG, Feb. 28, 2024 /PRNewswire/ -- Akeso (9926.HK) announced that the results of a phase II clinical trial for PD-1/CTLA-4 bispecific antibody­êcadonilimab­ëcombined with standard treatment (chemotherapy +/- bevacizumab) as [...]

PHILADELPHIA, Jan. 4, 2024 /PRNewswire/ -- Integral Molecular, a leading biotech company specializing in antibody discovery against undruggable protein targets, announced today that it has entered into an antibody license [...]

ZILBRYSQ(zilucoplan) is now commercially available by prescription in the United States and dispensed by UCB's selected exclusive specialty pharmacy PANTHERx Rare Pharmacy. ZILBRYSQ is FDA-approved as the first and only [...]

Ginkgo, under a grant from the Bill & Melinda Gates Foundation, will work to develop a live cell therapeutic that can produce antibodies to fight human immunodeficiency virus (HIV) and/or [...]

First-line therapy for gastric cancer and metastatic colorectal cancer, neoadjuvant therapy for hepatocellular carcinoma HONGKONG, Dec. 5, 2023 /PRNewswire/ -- Akeso (9926.HK) published results from three investigator-initiated trials (IITs) of [...]

Collaboration to leverage BigHat's Artificial Intelligence and Machine Learning (AI/ML) guided Milliner(TM) platform and AbbVie's expertise in Oncology and Neuroscience to develop next-generation antibodies BigHat to receive $30 million upfront [...]

FDA approval of RYSTIGGO(rozanolixizumab-noli) has been granted under the Priority Review designation for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) or anti-muscle-specific [...]

PHILADELPHIA, Jan. 5, 2023 /PRNewswire/ -- Integral Molecular, the industry leader in antibody discovery for membrane proteins, has published the targeting mechanism enabling best-in-class specificity of its Claudin 6 (CLDN6) [...]

SOLNA, Sweden, Dec. 20, 2022 /PRNewswire/ --As communicated earlier, Eurocine Vaccines is conducting preclinical trials to evaluate the mRNA and protein technology platforms for its therapeutic Herpes simplex virus type [...]

JERUSALEM, Sept. 20, 2022 /PRNewswire/ --BiondVax Pharmaceuticals Ltd.(Nasdaq: BVXV), which focuses on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses, today [...]

HANGZHOU and SHAOXING, China, Sept. 15, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, 'Ascletis') today announces that the clinical study of PD-L1 antibody ASC22 (Envafolimab) in combination with Chidamide [...]

SALT LAKE CITY, Sept. 13, 2022 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=3646196-1&h=1450013527&u=https%3A%2F%2Fwww.nanospot.ai%2F&a=NanoSpot.ai, producer of digital agglutination-based antibody tests, announced today that it has entered into a commercial and distribution agreement with https://c212.net/c/link/?t=0&l=en&o=3646196-1&h=916874566&u=https%3A%2F%2Fwww.optodx.com%2F&a=Opto%2C an [...]

Spear Bio Recognized by AACC for 'Best Abstract in Metabolomics' Poster WOBURN, Mass., Sept. 2, 2022 /PRNewswire/ -- Developer of an ultrasensitive protein detection platform, Spear Bio (https://c212.net/c/link/?t=0&l=en&o=3637260-1&h=2262245853&u=http%3A%2F%2Fwww.spear.bio%2F&a=www.spear.bio), presented its [...]

Enable Biosciences Reports Easier and Accurate SARS-CoV-2 Neutralizing Antibody Assay using Dried Blood Spot Samples SOUTH SAN FRANCISCO, Calif., Aug. 3, 2022 /PRNewswire/ -- Scientists at Enable Biosciences report a [...]

Researchers used virus-like particles to identify which mutations of the Omicron SARS-CoV-2 virus make it more effective at infecting cells and escaping antibodies SAN FRANCISCO, July 20, 2022 /PRNewswire/ -- [...]

- This research collaboration marks Antengene'sentry into the field of cellular medicines . SHANGHAI and HONG KONGJuly 19, 2022 /PRNewswire/ -- Antengene Corporation Limited ('Antengene' SEHK: 6996.HK), a leading innovative, [...]

The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China The amubarvimab/romlusevimab combination is the first locally-discovered and approved SARS-CoV-2 target-specific treatment in China, [...]

HANGZHOU and SHAOXING, China, July 3, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, 'Ascletis') today announces that the clinical study of PD-L1 antibody ASC22 in combination with Chidamide for [...]

Textbook-Changing Discovery from Experts at Cincinnati Children's Opens Doors to a New Wave of Improved Treatments for Deadly Infections CINCINNATI, June 8, 2022 /PRNewswire/ -- Scientists discovered years ago that [...]

Data on Farletuzumab Ecteribulin (MORAb-202) Showcase Eisai's Advanced Chemistry Capabilities and Commitment to Identifying Novel Approaches in Treating Cancer to Improve Outcomes for Patients Presentations Featuring Post-Hoc Analyses from the [...]

The test measures a relative concentration of neutralizing antibodies (NAbs) in patients recovering from COVID-19 PISCATAWAY, N.J., May 26, 2022 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=3548962-1&h=1612674813&u=https%3A%2F%2Fcts.businesswire.com%2Fct%2FCT%3Fid%3Dsmartlink%26url%3Dhttp%253A%252F%252Fwww.genscript.com%26esheet%3D52411267%26newsitemid%3D20210413006175%26lan%3Den-US%26anchor%3DGenScript%2BBiotech%2B%2528Netherlands%2529%2BBV%26index%3D1%26md5%3D2418066d4d4703aee4bb4c9dcd588a1b&a=GenScript+USA Inc., a subsidiary of GenScript Biotech Corporation [...]

Over $1M in Department of Defense funding to A-Alpha Bio will be used to generate protein-protein binding data using its AlphaSeq platform to train highly predictive machine learning models for [...]

- Potential Candidate as Broad-spectrum Therapeutic Agent for Coronavirus Diseases Caused by Different Coronaviruses, including Variants - OSAKA, Japan, Feb. 16, 2022 /PRNewswire/ -- The National Institutes of Biomedical Innovation, [...]

SUGGESTS superior cardiAC safety compared to mRNA AND ADENOVIRUS VECTOR vaccines VANCOUVER, BC, Feb. 16, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAX)('BioVaxys' or 'Company') announced [...]

FREMONT, Calif. and ROCKVILLE, Md., Feb. 15, 2022 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=3443143-1&h=2614601236&u=https%3A%2F%2Falamarbio.com%2F&a=Alamar+Biosciences(Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other [...]

Funding from the Bill & Melinda Gates Foundation will support the development of Aridis' inhaled formulation technology to deliver cost-effective monoclonal antibodies against influenza and COVID-19 Aridis Pharmaceuticals will host [...]

NORTH BRUNSWICK, N.J. and HANGZHOU, China, Jan. 26, 2022 /PRNewswire/ -- Adlai Nortye Ltd. ('Adlai Nortye'), a clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies, announced that [...]

The Pictor test simultaneously detects the presence of both anti-Spike (SP) antibody and anti-Nucleocapsid (NP) antibody in a single test. SAN FRANCISCO, Jan. 20, 2022 /PRNewswire-PRWeb/ -- New Zealand diagnostic [...]

- COVISHIELD (STI-9167) neutralizing antibody (nAb) was discovered by scientists from the Icahn School of Medicine at Mount Sinai ('Icahn Mount Sinai') and further optimized and engineered by Sorrento scientists. [...]

Recombinant Two-Component COVID-19 Vaccine (ReCOV) was approved for International Phase II/III Clinical Trial ReCOV induced high levels of neutralizing antibodies against SARS-CoV-2 and Variants of Concern such as Omicron and [...]

The Company Believes The Technology Could Have Much Broader Applications to Address Other Viruses Or The Next Emerging Pandemic Infection IDAHO FALLS, Idaho, Dec. 7, 2021 /PRNewswire/ -- International Isotopes [...]

CANTON, Mass. and SAN DIEGO, Nov. 11, 2021 /PRNewswire/ -- Abveris, a leader in antibody drug discovery, today announced that Prometheus Biosciences and Abveris have entered a multi-year collaboration to [...]

InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, announced that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for [...]

Study Designed to Assess IN-006 in Treating COVID-19 Patients at Home DURHAM, N.C., Oct. 7, 2021 /PRNewswire/ -- Inhalon Biopharma, Inc., a clinical-stage immunotherapy company developing an inhaled 'muco-trapping' antibody [...]

Data demonstrated a 78% reduction in the risk of hospitalization or death in patients receiving single dose treatment of BRII-196/BRII-198 with zero deaths, versus eight compared to placebo, through the [...]

ATLANTA, Sept. 27, 2021 /PRNewswire/ -- Scientists have created a new test to measure antibodies in girls who have received a vaccine for human papilloma virus (HPV), the leading cause [...]

Expanded emergency use authorization includes certain people who have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting INDIANAPOLIS, Sept. [...]

In this free webinar, the featured speakers will discuss Aji Bio-Pharma's novel method of affinity peptide-mediated regiodivergent antibody functionalization that enables the synthesis of antibody-drug conjugates (ADCs) from native IgGs [...]

SHANGHAI, Sept. 13, 2021 /PRNewswire/ -- Recently, Jemincare group has declared that it has completed phase I clinical trial of self-developed novel coronavirus specific neutralizing antibody (Project code: JMB2002). The [...]

GHENT, Belgium, Sept. 1, 2021 /PRNewswire/ -- ExeVir, which is developing single domain antibody therapies providing broad protection against viral infections, today announces that the first patient has been treated [...]

FLAGLER BEACH, Fla., Aug. 30, 2021 /PRNewswire/ -- Epitome Risk announces its https://c212.net/c/link/?t=0&l=en&o=3273699-1&h=1005958434&u=https%3A%2F%2Fwww.epitomerisk.com%2Fproduct%2Fneutralizing-antibody-test%2F&a=at-home+neutralizing antibody test is now sold online. 'Last week President Biden said U.S. health officials are considering Covid [...]

TARRYTOWN, N.Y., Aug. 20, 2021 /PRNewswire/ -- UK chief medical officers to confirm how antibody cocktail will be rolled-out on the National Health Service (NHS) in the coming weeks In [...]